Recent highlights and breakthroughs in immunotherapy for head and neck cancers
Recent advances highlight a rapid surge in positive immunotherapy trials across different head and neck cancer entities, with clinical benefit observed both when immune checkpoint inhibitors are moved earlier in the disease course and when they are combined with agents targeting resistance mechanisms or enabling more precise drug delivery to tumors.
Authors
- Joanna Vuille (ORCID: https://orcid.org/0000-0001-7713-9543)
- Petr Szturz (ORCID: https://orcid.org/0000-0001-9705-4168)
Institutions
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Current Opinion in Oncology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1097/cco.0000000000001211
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00